Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial.

Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S.

Clin Microbiol Infect. 2017 Mar;23(3):179-187. doi: 10.1016/j.cmi.2016.10.019. Epub 2016 Oct 26.

2.

Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.

Kolstad A, Laurell A, Jerkeman M, Grønbæk K, Elonen E, Räty R, Pedersen LB, Loft A, Bogsrud TV, Kimby E, Hansen PB, Fagerli UM, Nilsson-Ehle H, Lauritzsen GF, Lehmann AK, Sundstrom C, Karjalainen-Lindsberg ML, Ralfkiaer E, Ehinger M, Delabie J, Bentzen H, Schildt J, Kostova-Aherdan K, Frederiksen H, Brown Pde N, Geisler CH; Nordic Lymphoma Group.

Blood. 2014 May 8;123(19):2953-9. doi: 10.1182/blood-2013-12-541953. Epub 2014 Mar 20.

3.

Primary diffuse large B-cell lymphoma of the dura without systemic recurrence four years after diagnosis and successful therapy.

Berget E, Helgeland L, Lehmann AK, Smievoll AI, Vintermyr OK, Mørk SJ.

Acta Oncol. 2013 Jun;52(5):1047-9. doi: 10.3109/0284186X.2012.731526. Epub 2012 Oct 16. No abstract available.

PMID:
23072723
4.

The contribution of thioredoxin-2 reductase and glutathione peroxidase to H(2)O(2) detoxification of rat brain mitochondria.

Kudin AP, Augustynek B, Lehmann AK, Kovács R, Kunz WS.

Biochim Biophys Acta. 2012 Oct;1817(10):1901-6. doi: 10.1016/j.bbabio.2012.02.023. Epub 2012 Feb 28.

5.

Femoral bridge stability in double-bundle ACL reconstruction: impact of bridge width and different fixation techniques on the structural properties of the graft/femur complex.

Lehmann AK, Osada N, Zantop T, Raschke MJ, Petersen W.

Arch Orthop Trauma Surg. 2009 Aug;129(8):1127-32. doi: 10.1007/s00402-009-0869-x. Epub 2009 Apr 9.

PMID:
19357859
6.

Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.

Plested JS, Ferry BL, Coull PA, Makepeace K, Lehmann AK, MacKinnon FG, Griffiths HG, Herbert MA, Richards JC, Moxon ER.

Infect Immun. 2001 May;69(5):3203-13.

7.

Phagocytosis: measurement by flow cytometry.

Lehmann AK, Sornes S, Halstensen A.

J Immunol Methods. 2000 Sep 21;243(1-2):229-42. Review.

PMID:
10986417
8.

Concurrent measurement of antigen- and antibody-dependent oxidative burst and phagocytosis in monocytes and neutrophils.

Bassøe CF, Smith I, Sørnes S, Halstensen A, Lehmann AK.

Methods. 2000 Jul;21(3):203-20.

PMID:
10873475
9.

Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication.

Smith I, Lehmann AK, Lie L, Digranes A, Caugant DA, Høiby EA, Frøholm LO, Halstensen A.

Epidemiol Infect. 1999 Dec;123(3):373-82.

10.

Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes.

Lehmann AK, Gorringe AR, Reddin KM, West K, Smith I, Halstensen A.

Infect Immun. 1999 Dec;67(12):6526-32.

11.

Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.

Lehmann AK, Halstensen A, Aaberge IS, Holst J, Michaelsen TE, Sornes S, Wetzler LM, Guttormsen H.

Infect Immun. 1999 May;67(5):2552-60.

12.
13.

Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.

Rosenqvist E, Høiby EA, Bjune G, Aase A, Halstensen A, Lehmann AK, Paulssen J, Holst J, Michaelsen TE, Nøkleby H, Frøholm LO, Closs O.

Dev Biol Stand. 1998;92:323-33.

PMID:
9554288
14.

Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis.

Lehmann AK, Halstensen A, Holst J, Bassøe CF.

J Immunol Methods. 1997 Jan 15;200(1-2):55-68.

PMID:
9005944
15.

High levels of interleukin 10 in serum are associated with fatality in meningococcal disease.

Lehmann AK, Halstensen A, Sørnes S, Røkke O, Waage A.

Infect Immun. 1995 Jun;63(6):2109-12.

16.

[Research interest and recruitment potential--medical students and research].

Lehmann AK, Hexeberg E, Engebråten O, Bjugn R.

Tidsskr Nor Laegeforen. 1992 Jun 30;112(17):2205-7. Norwegian.

PMID:
1523658
17.

[Working conditions of medical students--medical students and research].

Lehmann AK, Bjugn R, Engebråten O, Hexeberg E.

Tidsskr Nor Laegeforen. 1992 Jun 30;112(17):2202-4. Norwegian.

PMID:
1523657
18.

Serum opsonins to serogroup B meningococci after disease and vaccination.

Halstensen A, Lehmann AK, Guttormsen HK, Vollset SE, Bjune G, Naess A.

NIPH Ann. 1991 Dec;14(2):157-65; discussion 166-7.

PMID:
1812430
19.

Immunization against serogroup B meningococci. Opsonin response in vaccinees as measured by chemiluminescence.

Lehmann AK, Halstensen A, Naess A, Vollset SE, Sjursen H, Bjune G.

APMIS. 1991 Aug;99(8):769-72.

PMID:
1907153
20.

[Research training--what trainees think about future research education].

Bjugn R, Indrekvam K, Flø RW, Aarli A, Frostad S, Lehmann AK, Houge G, Hexeberg E.

Tidsskr Nor Laegeforen. 1990 Mar 10;110(7):862-4. Norwegian.

PMID:
2321217
21.

[Research training--the work situation of research trainees at the School of Medicine, University of Bergen].

Hexeberg E, Houge G, Lehmann AK, Frostad S, Aarli A, Flø RW, Indrekvam K, Bjugn R.

Tidsskr Nor Laegeforen. 1990 Mar 10;110(7):859-62. Norwegian.

PMID:
2321216

Supplemental Content

Loading ...
Support Center